About the Company
nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NMRD News
The Nemaura Medical (NASDAQ:NMRD) Share Price Is Down 63% So Some Shareholders Are Wishing They Sold
Nemaura Medical Inc. (NASDAQ:NMRD) shareholders should be happy to see the share price up 14% in the last week. But that's not enough to compensate for the decline over the last twelve months.
Nemaura Medical (NASDAQ: NMRD)
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT.
Nemaura Medical Inc N18A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting ...
Nasdaq Down Over 100 Points; Sidus Space Shares Spike Higher
Inc. (NASDAQ: ESPR) were down 21% to $2.2950 after the company announced a $125 million amendment to the collaboration with ...
Nemaura Medical Inc. (NMRD)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Form 8-K - Current report
Item 5.07. Submission of Matters to a Vote of Security Holders. On February 26, 2024, Nemaura Medical Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting ...
VIVE Viveve Medical, Inc.
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function ...
TNON Tenon Medical, Inc.
MHUAMeihua International Medical Technologies Co., Ltd.
Nasdaq Inc. Buy Rating: EPS Growth, Valuation Expansion, and Strong FinTech Prospects
In a report released today, Alexander Blostein from Goldman Sachs upgraded Nasdaq (NDAQ – Research Report) to a Buy, with a price target ...
Shockwave Medical Inc SWAV
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
iCAD, Inc. (ICAD)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Loading the latest forecasts...